Low-Dose Rituximab May Keep RA Activity Low in Responders Low-Dose Rituximab May Keep RA Activity Low in Responders

Rituximab doses as low as 200 mg were effective in treating rheumatoid arthritis, an extension study of a small trial in the Netherlands found.Medscape Medical News
Source: Medscape Rheumatology Headlines - Category: Rheumatology Tags: Rheumatology News Source Type: news